Viewing Study NCT04947956


Ignite Creation Date: 2025-12-24 @ 11:31 PM
Ignite Modification Date: 2025-12-30 @ 7:39 PM
Study NCT ID: NCT04947956
Status: UNKNOWN
Last Update Posted: 2021-07-01
First Post: 2021-06-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Camrelizumab in Patients With Unresectable Hepatocellular Carcinoma
Sponsor: Shanghai Zhongshan Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module